Clazolam
From Wikipedia, the free encyclopedia
Jump to: navigation, search
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
2-chloro-5-methyl-5,9,10,14b-tetrahydroisoquino[2,1-d][1,4]benzodiazepin-6(7H)-one
|
|
| Identifiers | |
| CAS Number | 7492-29-7 10171-69-4 (HCl) |
| ATC code | None |
| PubChem | CID 24107 |
| ChemSpider | 22534 |
| UNII | YJ53T77095  Y |
| KEGG | D03531 |
| ChEMBL | CHEMBL1723823 |
| Chemical data | |
| Formula | C18H17ClN2O |
| Molar mass | 312.79 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
Clazolam[1] (SAH-1123), also referred to as isoquinazepon, is a drug which is a fused benzodiazepine and tetrahydroisoquinoline derivative.[2] It was developed in the 1960s but was never marketed.[2] It possesses anxiolytic effects and is also claimed to have antidepressant properties.[2][3]
See also[edit]
References[edit]
- ^ NL Patent 6510987
- ^ a b c David J. Triggle (1997). Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 0-412-46630-9.
- ^ Potikha LM, Kovtunenko VA (2009). "Synthesis and properties of 3-aminodihydroisoquinolines". Russian Chemical Reviews. 78 (6): 513–533. doi:10.1070/RC2009v078n06ABEH004041.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Clazolam&oldid=744762963"
